INmune Bio, Inc.
INMB
$7.32
$0.010.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.92M | 33.55M | 31.07M | 26.00M | 35.85M |
| Total Receivables | 1.41M | 1.42M | 3.41M | 2.69M | 2.44M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 331.00K | 879.00K | 1.01M | 1.13M | 1.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.66M | 35.85M | 35.50M | 29.82M | 39.94M |
|
|
|||||
| Total Current Assets | 22.66M | 35.85M | 35.50M | 29.82M | 39.94M |
| Net Property, Plant & Equipment | 307.00K | 335.00K | 363.00K | 389.00K | 414.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 16.51M | 16.51M | 16.51M | 16.51M | 16.51M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 79.00K | 82.00K | 81.00K | 106.00K | 131.00K |
| Total Assets | 39.56M | 52.78M | 52.45M | 46.83M | 57.00M |
|
|
|||||
| Total Accounts Payable | 6.54M | 10.59M | 9.28M | 9.29M | 7.90M |
| Total Accrued Expenses | 25.00K | 55.00K | 139.00K | 56.00K | 35.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 140.00K | 2.63M | 5.11M | 7.58M | 10.04M |
| Total Finance Division Other Current Liabilities | 517.00K | 549.00K | 521.00K | 520.00K | 489.00K |
| Total Other Current Liabilities | 517.00K | 549.00K | 521.00K | 520.00K | 489.00K |
| Total Current Liabilities | 7.22M | 13.82M | 15.05M | 17.45M | 18.47M |
|
|
|||||
| Total Current Liabilities | 7.22M | 13.82M | 15.05M | 17.45M | 18.47M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 244.00K | 284.00K | 322.00K | 360.00K | 397.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.47M | 14.11M | 15.37M | 17.81M | 18.86M |
|
|
|||||
| Common Stock & APIC | 195.78M | 193.60M | 178.79M | 160.94M | 159.16M |
| Retained Earnings | -163.10M | -153.89M | -141.79M | -132.05M | -121.02M |
| Treasury Stock & Other | -575.00K | -1.04M | -713.00K | -669.00K | -799.00K |
| Total Common Equity | 32.10M | 38.68M | 36.28M | 28.22M | 37.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | 799.00K | 799.00K | 799.00K |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 799.00K | 799.00K | 799.00K |
|
|
|||||
| Total Common Equity | 32.10M | 38.68M | 36.28M | 28.22M | 37.34M |
| Total Preferred Equity | -- | -- | 799.00K | 799.00K | 799.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.10M | 38.68M | 37.08M | 29.02M | 38.14M |
|
|
|||||